1 The FLOW trial achieved its primary endpoint with Ozempic 1 mg, demonstrating a statistically significant and superior 24% relative risk reduction of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease (4.9% absolute risk reduction at 3 years) compared to placebo, when added to standard of care
75 Bariatric surgery: VSG Bariatric surgery is used to treat obesity and its related comorbidities
These exercises help ensure that weight loss comes primarily from fat rather than muscle tissue
To view or add a comment, sign in Sterile Injectable Drugs Market to Reach USD 882 Billion by 2030
The risk of clinically significant insomnia outweighs the benefit of partial afternoon coverage
New England Journal of Medicine, 392(7), 612615